Mutational analysis of CDKN2A gene in a group of 390 larynx cancer patients
Related Experiment Video
Updated: Jun 20, 2026

Ultra-Fast Amplicon-Based Next-Generation Sequencing in Non-Squamous Non-Small Cell Lung Cancer
Published on: September 8, 2023
Katarzyna Kiwerska1, Małgorzata Rydzanicz, Andrzej Kram
1Department of Environmental Mutagenesis, Institute of Human Genetics, Polish Academy of Sciences, Poznań, Poland. kassz@man.poznan.pl
Abstract:
CDKN2A gene belongs to the genes involved in cell cycle regulation. When is absent or inactivated by mutation or promoter hypermethylation a cell may undertake an uncontrolled proliferation. Inactivation of CDKN2A gene is observed in many human malignancies, including larynx cancer. In this study we investigated mutations in exon 1 and exon 2 of CDKN2A gene in a large group of 390 laryngeal cancers. We found 40 different alterations (17%) and nearly half of them was not described previously. Out of these alterations two transversions in codon 108: c.322G>C (Asp108His) and c.322G>T (Asp108Tyr) as well as a G>A transition in codon 110 (Trp110X) were found more frequently (altogether: 7 cases in codon 108 and 10 cases in codon 110). This result, concerning the location of these codons in the ankyrin repeat structures, may suggest that these two codons may be critical hot-spots in larynx carcinogenesis.
Insights
The CDKN2A gene, crucial for cell cycle regulation, is often inactivated in larynx cancer. This study identified frequent mutations in specific codons of CDKN2A, suggesting they are critical hotspots in larynx carcinogenesis.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- The CDKN2A gene plays a vital role in regulating the cell cycle.
- Inactivation of CDKN2A contributes to uncontrolled cell proliferation and is implicated in various human malignancies, including larynx cancer.
Purpose of the Study:
- To investigate mutations within exon 1 and exon 2 of the CDKN2A gene in a cohort of laryngeal cancer patients.
- To identify novel alterations and recurring mutation hotspots within the CDKN2A gene associated with larynx carcinogenesis.
Main Methods:
- Genomic DNA was extracted from 390 laryngeal cancer samples.
- Exons 1 and 2 of the CDKN2A gene were analyzed for mutations using sequencing techniques.
Main Results:
- A total of 40 distinct CDKN2A alterations were identified in 17% of the laryngeal cancer samples, with a significant proportion being novel.
- Specific mutations, including transversions at codon 108 (Asp108His, Asp108Tyr) and a transition at codon 110 (Trp110X), were found with notable frequency.
- These frequently mutated codons are located within ankyrin repeat structures, indicating potential functional significance.
Conclusions:
- The study identified several novel and recurrent mutations in the CDKN2A gene in laryngeal cancer.
- Codons 108 and 110 within the CDKN2A gene appear to be critical hotspots for mutations in larynx carcinogenesis, suggesting their importance in tumor development.
Related Concept Videos
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Cancers Originate from Somatic Mutations in a Single Cell
